Reinhard Ehret

Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3)

Wolfgang H. Oertel, Karla Eggert, Rajesh Pahwa et al. · Movement Disorders · 2017 · 167 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial

Claudia Trenkwalder, К. Ray Chaudhuri, Pablo Martínez‐Martín et al. · The Lancet Neurology · 2015 · 122 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +16

Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel

Thomas Müller, Constanze Jugel, Reinhard Ehret et al. · Journal of Neural Transmission · 2011 · 52 citations

Life Sciences, Neurology, Neuroscience +12

Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (PiViCog-PD)

Karla Eggert, Christian Ohlwein, Jan Kassubek et al. · Clinical Neuropharmacology · 2014 · 36 citations

Medicine, Neurology, Pharmacology +17

Ergoline and non-ergoline derivatives in the treatment of Parkinson’s disease

Heinz Reichmann, A. Bilsing, Reinhard Ehret et al. · Journal of Neurology · 2006 · 31 citations

Medicine, Medicinal Chemistry, Pharmacology +13